The Catalytic Impact Foundation aggregates philanthropic capital to invest in transformative early-stage companies with technologies that focus on high unmet medical need, and have the potential to create lasting impact in health. 

We invest broadly in health and life science, but are particularly committed to supporting companies within the verticals of Women’s Health, Brain Health, and Pediatric Rare Disease, Pediatric Health and Aging; three areas where there is a significant lack of funding.

We are also an enthusiastic funder of women-led companies through our Women Leaders in Health Innovation Initiative, with supporting women entrepreneurs serving as a key criteria in investment considerations.